Efficacy and Safety of Tiropramide in the Treatment of Patients With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-blind, Non-inferiority Trial, Compared With Octylonium

BACKGROUND/AIMS: Antispasmodics such as octylonium are widely used to manage irritable bowel syndrome (IBS) symptoms. However, the efficacy and safety of another antispasmodic, tiropramide, remain uncertain. We aimed to evaluate the efficacy and safety of tiropramide compared with octylonium in pati...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lee, Kang Nyeong, Lee, Oh Young, Choi, Myung-Gyu, Sohn, Chong Il, Huh, Kyu Chan, Park, Kyung Sik, Kwon, Joong Goo, Kim, Nayoung, Rhee, Poong-Lyul, Myung, Seung-Jae, Lee, Joon Seong, Lee, Kwang Jae, Park, Hyojin, Lee, Yong Chan, Choi, Suck Chei, Jung, Hye-Kyung, Jee, Sam Ryong, Choi, Chang Hwan, Kim, Gwang Ha, Park, Moo In, Sung, In Kyung
Format: Artigo
Idioma:Inglês
Publicat: Korean Society of Neurogastroenterology and Motility 2014
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3895597/
https://ncbi.nlm.nih.gov/pubmed/24466452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5056/jnm.2014.20.1.113
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars